Extreme Movers: Perplexity's picks for 2026-10-21
Perplexity picked BRZE, IRON, EFX, HAS, GM for a 1-day horizon. Average directional return: -1.76%. Directions called correctly: 40%.
| Experiment | Extreme Movers |
|---|---|
| Model | Perplexity |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-21 |
| Measured to | 2026-10-22 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -1.76% |
| Directions called correctly | 40% |
| Benchmark return | -0.55% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | BRZE | up | +0.60% | +0.60% | 78% | +1.15% | Yes |
| 2 | IRON | up | -4.18% | -4.18% | 72% | -3.63% | No |
| 3 | EFX | down | +4.25% | -4.25% | 65% | -3.71% | No |
| 4 | HAS | down | +1.31% | -1.31% | 62% | -0.76% | No |
| 5 | GM | up | +0.33% | +0.33% | 60% | +0.88% | Yes |
The model's market view
US equities rose modestly on October 20, 2026 with S&P 500 +0.32% and Dow +0.9% while Nasdaq was flat, led by rotation into healthcare and financials. Earnings-driven moves dominated single-name volatility, with large-cap beats and deal announcements creating outsized gaps that often see partial fade or follow-through into the next session.
Why each pick
BRZE
Top gainer on October 20, closed +51.7% to $45.57 after Salesforce agreed to acquire Braze for $5.66B enterprise value at $47.50 per share in cash. Catalyst is substantive M&A with definitive price, placing a near-term ceiling near $47.50. Volume was 42.7M vs average ~3M, 14x normal. Previous change +51.7% is source session close-to-close. Market cap $5.18B as of Oct 21, price >= $5, average daily traded value 64.51M USD > $20M floor. Continuation up toward deal price expected as arb spread closes.
IRON
Disc Medicine led Trefis gainers on Oct 20 with +38.9% on new ARC-20 data for casdatifan in kidney cancer and positive trial readouts. Catalyst is substantive clinical data. Price $79.48 close Oct 20, market cap $3.05B as of Oct 20-21, average daily traded value 44.71M USD. Biotech momentum often sees continuation when data is strong and volume confirms. Previous change +38.9% from Trefis coverage universe $300M+ screen.
EFX
Top S&P 500 gainer Oct 20 at +11.33% to $176.54 after Q3 revenue $1.693B up 10% and adjusted EPS $2.26 beating $2.20 consensus. Earnings-driven pop gapped from prior close $158.57 open $166.11 on volume 2x normal. Market cap $20.75B, average daily traded value 307.09M USD, well above floors. Historical pattern is gap up then partial fade as guidance not raised significantly. Expect reversal down.
HAS
Second biggest S&P 500 gainer Oct 20 +11.20% to $109.52 after Q3 EPS $2.90 beating $1.86 estimate by $1.04, revenue $1.595B up 15%, raising FY26 outlook and doubling buyback. Catalyst substantive earnings beat. Market cap $13.93B finnhub and $15.45B market-value conversion on session, average daily traded value 169.09M USD. Consumer discretionary into earnings often sees profit-taking next day after +4.2x relative volume. Predict reversal down.
GM
Biggest S&P 500 loser Oct 20 -6.84% to $77.09 despite Q3 adjusted EPS $3.70 beating $3.63, on narrowed FY26 guidance and profit pressure concerns plus $20B buyback announcement. Substantive catalyst mixed beat but outlook miss. Market cap ~$77B, average daily traded value 632.9M USD, price $77.09 close. Oversold reaction to guidance tightening often rebounds next session as buyback support noted. Previous change -6.84% so reversal hypothesis is up.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Muse Spark 1.1 | BRZE, IRON, EFX, HAS, GM | -1.76% | 40% |
| Grok 4.5 | BRZE, GM, DVA, SMCI, SPCX | -2.13% | 40% |
| DeepSeek | BRZE, GM, EFX, GPC, HAS | -0.23% | 60% |
| Gemini 3.6 Flash High | BRZE, GM, DVA, SMCI, SPCX | -2.13% | 40% |
| GPT-6 Thinking | TSLA, NVDA, AMD, META, AMZN | +0.12% | 20% |
| Claude Sonnet 5.5 | HAS, SE, GM, EFX, DVA | -1.53% | 40% |
Written up on ForecastNest Insights: Extreme Movers: Perplexity's picks for 2026-10-21.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.